Teleflex Incorporated (TFX)
| Market Cap | 11.14B |
| Revenue (ttm) | 3.01B |
| Net Income (ttm) | 263.57M |
| Shares Out | 47.12M |
| EPS (ttm) | 5.56 |
| PE Ratio | 42.30 |
| Forward PE | 16.03 |
| Dividend | $1.36 (0.58%) |
| Ex-Dividend Date | Aug 15, 2024 |
| Volume | 241,097 |
| Open | 239.31 |
| Previous Close | 239.94 |
| Day's Range | 235.44 - 239.81 |
| 52-Week Range | 177.63 - 257.85 |
| Beta | 1.16 |
| Analysts | Buy |
| Price Target | 265.14 (+12.15%) |
| Earnings Date | Oct 31, 2024 |
About TFX
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional prod... [Read more]
Financial Performance
In 2023, Teleflex's revenue was $2.97 billion, an increase of 6.57% compared to the previous year's $2.79 billion. Earnings were $356.33 million, a decrease of -1.88%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $265.14, which is an increase of 12.15% from the latest price.
News
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low incid...
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m....
Teleflex's Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
• Highlights include new safety and efficacy data of Barrigel ™ rectal spacer, the first and only sculptable rectal spacer 1 - 3
Teleflex™ Chooses o9's AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
DALLAS--(BUSINESS WIRE)--o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that Teleflex Incorporated (NYSE: TFX), a leading global ...
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
WAYNE, Pa., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 22nd Annual Global Healthcare Conf...
Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant Procedural Efficiency Compared with Traditional Surgical Staplers
WAYNE, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of a new retrospective analysis of c...
5 Stocks That Have Bucked August's Selloff, and How They've Done It
August has already made it a cruel summer for stocks.
Teleflex Incorporated (TFX) Q2 2024 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly ...
Teleflex raises 2024 profit forecast on medical device demand
Surgical equipment maker Teleflex raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals to drive sales for its medical devices.
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of...
Teleflex Reports Second Quarter Financial Results and Full Year 2024 Outlook
Announces $500 million share repurchase authorization inclusive of a $200 million accelerated share repurchase of common stock Announces $500 million share repurchase authorization inclusive of a $200...
Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
This milestone highlights Teleflex's commitment to providing interventionalists with new tools specifically engineered to address unmet clinical needs. This milestone highlights Teleflex's commitment ...
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
Hemostatic Dressings and Devices are Now Available at Special Pricing for Premier Members Hemostatic Dressings and Devices are Now Available at Special Pricing for Premier Members
Teleflex Announces the Teleflex Center for Antimicrobial Protection
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimic...
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m...
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex Inc TFX benefited in the first quarter from the surge in the interventional segment and other tailwinds.
US FDA classifies recall of Teleflex's inflatable devices as 'most serious'
The U.S. Food and Drug Administration classified a recall of Teleflex's inflatable devices that increase blood supply to the heart muscle as "most serious".
Teleflex Publishes 2023 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug Administration
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 America...
Teleflex: Compelling, Despite Some Operational Hiccups
Teleflex is a medical device and instrument manufacturer with $3 billion in sales, supplying a wide range of products.
Teleflex Incorporated (TFX) Q1 2024 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX) Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Company Participants Lawrence Keusch – Vice President-Investor Relations and Strategy Development Liam Kelly –...
Teleflex beats quarterly profit estimates on healthy demand for medical devices
Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices.
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
WAYNE, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 31, 2024.
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
WAYNE, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of multiple clinical studies at the 2024 Ameri...